CenTrial Logo

Can Tuberculosis Vaccine Protect Older Adults Against COVID-19?


Clinical trial finds tuberculosis vaccine ineffective against Covid-19

Can the tuberculosis BCG vaccine provide protection against respiratory infections, including COVID-19, in older adults? A recent multicenter clinical trial aimed to answer this question by randomly assigning 2,014 individuals aged 60 years or older to receive either the BCG vaccine or a placebo. The primary endpoint was the cumulative incidence of respiratory tract infections requiring medical intervention over a 12-month period, while secondary endpoints included the incidence of COVID-19 and the effect of BCG vaccination on immune responses.

Clinical trial

The study found that BCG vaccination did not have a significant impact on the incidence of respiratory tract infections, including COVID-19, compared to the control group. However, BCG vaccination was associated with enhanced cytokine responses after influenza and SARS-CoV-2 stimulation and induced stronger antibody titers after COVID-19 infection.

The BCG vaccine has been proposed as a potential preventive strategy against COVID-19 due to its ability to provide heterologous protection against nontuberculous infections. However, the results of this clinical trial suggest that BCG vaccination may not be effective in preventing respiratory infections in older adults.

Despite this, the study's findings on the vaccine's ability to enhance immune responses to viral infections such as influenza and COVID-19 are promising. This suggests that the BCG vaccine could potentially play a role in boosting the immune system's ability to fight off viral infections in older adults.

Are you interested in clinical trials near you?

You can receive free notification of a trial for this, or any other condition, by completing a short confidential health profile.
Find a clinical trial near me

It's important to note that this clinical trial only focused on individuals aged 60 years or older. Further studies are needed to determine the efficacy of BCG vaccination in younger age groups and to explore the vaccine's potential as a preventive strategy against respiratory infections and COVID-19.

In the meantime, it's essential to continue practicing preventive measures to reduce the risk of respiratory infections, including COVID-19. These measures include regular handwashing, wearing masks in public places, maintaining physical distance from others, and getting vaccinated against COVID-19 when eligible.


The BCG vaccine did not have a significant impact on the incidence of respiratory tract infections, including COVID-19, in older adults. However, the vaccine's ability to enhance immune responses to viral infections is promising and warrants further research. As we continue to navigate the COVID-19 pandemic, it's crucial to follow preventive measures and get vaccinated when eligible to reduce the risk of respiratory infections.


Share this article with a friend:

Get emailed clinical trial results in the categories of your choice:
Free subscription to clinical trial results

Whether you're healthy or have a medical condition you can participate in a clinical trial.
Signup and be matched to trials near you
This free service will notify you of current and future clinical trial matches.

This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers/viewers of this content are advised to consult their doctors or qualified health professionals regarding specific health questions. CenTrial Data Ltd. does not take responsibility for possible health consequences of any person or persons reading or following the information in this educational content. Treatments and clinical trials mentioned may not be appropriate or available for all trial participants. Outcomes from treatments and clinical trials may vary from person to person. Consult with your doctor as to whether a clinical trial is a suitable option for your condition. Assistance from generative AI tools may have been used in writing this article.